The existing hypothesis “There is not enough insulin” can be activated only for patients with diabetes type 1 and for patients with diabetes type 2 on insulin therapy, while a new hypothesis “medication is not taken” can be created and activated for a patient with type 2 diabetes for example. The gene discussed is INS; the disease is type 2 diabetes mellitus.